Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Humacyte Leadership and Investigators to Present at Five Scientific Events in May
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Humacyte Receives $50M Debt Facility From Silicon Valley Bank
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Humacyte to Present at Oppenheimer 31st Annual Healthcare Conference
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Chief Executive Officer, will present at the virtual Oppenheimer 31st Annual Healthcare Conference March 18, 2021, at 8:40 a.m. EDT.
On February 17, 2021, Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, and Humacyte announced the execution of a definitive business combination agreement along with a fully committed $175 million PIPE financing agreement.
The webcast will be available for replay for 30 days following the presentation and can be accessed at www.Humacyte.com and https://wsw.com/webcast/oppenheimer9/register.aspx?conf=oppenheimer9&page=huma&url=https://wsw.com/webcast/oppenheimer9/huma/2712391.